A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex).

Trial Profile

A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex).

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Feb 2017

At a glance

  • Drugs Triptorelin (Primary) ; Goserelin
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Acronyms EDVART
  • Most Recent Events

    • 18 Feb 2017 Final results assessing effect of decapeptyl compared with zoladex preradiotherapy on quality of life, presented at the 2017 Genitourinary Cancers Symposium
    • 17 Jun 2013 Accrual to date is 110% according to United Kingdom Clinical Research Network.
    • 06 Jun 2013 Accrual to date is 98% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top